Rosanne
Rosanne Badowski, Palm Beach Gardens, FL US
Patent application number | Description | Published |
---|---|---|
20140000926 | CORD COVER | 01-02-2014 |
Rosanne Bonjouklian, Zionsville, IN US
Patent application number | Description | Published |
---|---|---|
20080227839 | Kinase Inhibitors - The present invention provides kinase inhibitors of Formula I: | 09-18-2008 |
20090036445 | KINASE INHIBITORS - The present invention provides kinase inhibitors of Formula I. | 02-05-2009 |
20090318443 | KINASE INHIBITORS - The present invention provides kinase inhibitors of Formula I. | 12-24-2009 |
Rosanne Spolski, Ellicott City, MD US
Patent application number | Description | Published |
---|---|---|
20080305076 | METHOD OF INDUCING MEMORY B CELL DEVELOPMENT AND TERMINAL DIFFERENTIATION - A method is disclosed herein for inducing differentiation of a B cell progenitor into a memory B cells and/or a plasma cell. The method includes contacting a population of cells including a mature B cell or a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. In one embodiment, the B cell progenitor is an immature B cell. A method is also disclosed for enhancing an immune response. The method includes contacting a population of cells including a B cell progenitor with an effective amount of IL-21, and isolating memory B cells or plasma cells. The memory B cells and/or the plasma cell are then introduced into the subject to enhance the immune response. A method is also disclosed for treating a subject with a condition comprising a specific deficiency of at least one of memory B cells and plasma cells. A method is disclosed for identifying an agent with a physiological effect on one or more of a memory B cell and a plasma cell differentiation. A method is also disclosed for identifying agents that inhibit an activity of IL-21. Methods are also disclosed for inducing apoptosis of a B cell and for decreasing the number of B cells. A method is also described for producing a B cell hybridoma. | 12-11-2008 |
20100135958 | METHOD FOR TREATING CANCER IN HUMANS - A method of treating and/or preventing cancer in a subject, preferably mammalian, more preferably human, by administering in an effective amount IL-21 polypeptide, polynucleotide, vector comprising an IL-21 nucleic acid sequence encoding an IL-21 polypeptide, variants, and fragments thereof, thereby acting as an anti-cancer agent by reducing, ameliorating, and/or eliminating the cancer; and a method of treating and/or preventing cancer in a subject by co-administering the IL-21 polypeptide, polynucleotide, IL-21 vector, variant, and fragments thereof, with an immunotherapeutic and/or chemotherapeutic agent for the treatment and/or prevention of cancer in a subject. | 06-03-2010 |
Rosanne Spolski, Silver Spring, MD US
Patent application number | Description | Published |
---|---|---|
20150030562 | METHODS OF TREATING OR PREVENTING VIRAL DISEASES BY BLOCKING INTERLEUKIN-21 - The invention provides a method of treating or preventing viral diseases in a mammal comprising administering to the mammal an interleukin (IL)-21 blocking agent in an amount effective to treat or prevent the viral disease in the mammal. Also provided is a method of reducing the activation or recruitment of immune cells in a mammal comprising administering to the mammal an IL-21 blocking agent in an amount effective to reduce the activation or recruitment of immune cells in the mammal. Methods of decreasing the expression of at least one cytokine or at least one protein in a mammal comprising administering to the mammal an IL-21 blocking agent in an amount effective to decrease the expression of the cytokine or the protein are also provided. | 01-29-2015 |
Rosanne Welchert, Ventura, CA US
Patent application number | Description | Published |
---|---|---|
20110167930 | INFORMATION NOTIFICATION SAMPLE PROCESSING SYSTEM AND METHODS OF BIOLOGICAL SLIDE PROCESSING - A sample processing system that may be automated and methods are disclosed where samples are arranged on a carrier element and a process operation control system automatically processes the samples perhaps robotically with an operationally-influential exteriorly-consequential information monitor or a data capture element. Significant process details as well as operationally-influential exteriorly-consequential information may be monitored and an automatic notice element may cause notification of a person at some display that may be remote. Various people may be notified, such as an administrator, a supplier, or a manufacturer of an opportunity for some action such as reagent reordering or the like. A simulated motion display may be included to “watch” simulated operation in real time or long after completion of the actual processing. | 07-14-2011 |